Vendor Analysis
published on May 07, 2021
Report Overview:
This NelsonHall vendor assessment analyzes Hudson RPO's offerings and capabilities in Next Generation Contingent Talent Services and MSP.
Who is this Report for:
NelsonHall’s CWS/MSP profile on Hudson RPO is a comprehensive assessment of Hudson RPO’s offerings and capabilities, designed for:
- Sourcing managers monitoring the capabilities of existing suppliers of CWS/MSP and identifying vendor suitability for CWS/MSP RFPs
- Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
- Financial analysts and investors specializing in the CWS/MSP sector.
Scope of this Report:
The report provides a comprehensive and objective analysis of Hudson RPO’s CWS/MSP offerings and capabilities, and market and financial strengths, including:
- Identification of the company’s strategy, emphasis, and new developments
- Analysis of the company’s strengths, weaknesses, and outlook
- Revenue/SUM estimates
- Analysis of the profile of the company’s customer base including the company’s targeting strategy and examples of current contracts
- Analysis of the company’s offerings and key service components
- Analysis of the company’s service delivery organization (including delivery locations).
Key Findings & Highlights:
This NelsonHall vendor assessment analyzes Hudson RPO’s offerings and capabilities in CWS/MSP.
Since 1999, Hudson RPO has delivered innovative, customized recruitment outsourcing and talent solutions to organizations worldwide. It works with organizations to develop creative, flexible, and cost-effective talent solutions that drive businesses forward.
Hudson RPO predominantly offers MSP solutions and Total Talent solutions (with a mix of MSP, other CWS, and RPO components).
Hudson RPO added several new services to its portfolio in 2020. It also made enhancements to its proprietary InGenium platform.
Hudson RPO is technology agnostic and has a tech ecosystem comprising proprietary and third-party platforms.
Hudson RPO serves enterprise and mid-sized clients across all sectors and has seen traction in technology and pharmaceuticals.